Todd Demmy, MD, FACS

PrintE-mail
Clinical Chair, Department of Thoracic Surgery
Professor of Oncology
Roswell Park Cancer Institute
Professor of Surgery
School of Medicine and Biomedical Sciences, State University of New York at Buffalo

Profile

Areas of Expertise: 
Esophageal cancer
Lung cancer
Mesothelioma

Research

Research Interests: 
Advanced minimally invasive thoracic surgical procedures
Pain management after thoracic surgery
Management of malignant pleural effusions
Regional lung chemotherapy
Quality of life after thoracic surgery

Background Information

Education and Training: 
MD - Jefferson Medical College, Philadelphia, PA
Residency: 
General Surgery, Baylor College of Medicine, Houston, TX
Thoracic Surgery, Medical College of Pennsylvania-Allegheny General Hospital, Pittsburgh, PA
Board Certification: 
Surgery, American Board of Surgery
Surgical Critical Care, American Board of Surgery
Thoracic Surgery, American Board of Thoracic Surgery

Publications

Publications: 
  • Bhaskarla A, Tang PC, Mashtare T, Nwogu CE, Demmy TL, Adjei AA, Reid ME, Yendamuri S. Analysis of second primary lung cancers in the SEER database. Journal of surgical research 2010; 162(1):1-6
  • Demmy TL, Nwogu CE, Yendamuri S. Thoracoscopic chest wall resection: what is its role?. Annals of thoracic surgery 2010; 89(6):S2142-S2145
  • Nwogu CE, Yendamuri S, Demmy TL. Does thoracoscopic pneumonectomy for lung cancer affect survival?. Annals of thoracic surgery 2010; 89(6):S2102-S2106
  • Ettinger DS , Krug LM , Le QT , Lennes IT , Martins R , Malley JO , Osarogiagbon RU , Otterson GA , Patel JD , Pisters KM , Reckamp K , Riely GJ , Rohren E , Swanson SJ , Wood DE , Kris MG , Kong FM , Akerley W , Bepler G , Blum MG , Chang A , Cheney RT , Chineac LR , Amico TAD , Demmy TL , Govindan R , Grannis FW , Jahan T , Johnson DH , Kessinger A , Komaki R , Yang SC. Thymic malignancies. Journal of the National Comprehensive Cancer Network : JNCCN 2010; 8(11):1302-1315
  • Yendamuri S , Gutierrez L , Oni A , Mashtare T , Khushalani N, Yang G , Nava H , Demmy T , Nwogu C. Does circular stapled esophagogastric anastomotic size affect the incidence of postoperative strictures?. Journal of surgical research 2011; 165(1):1-4
  • Kachare S, Dexter EU, Nwogu C, Demmy TL, Yendamuri S. Perioperative outcomes of thoracoscopic anatomic resections in patients with limited pulmonary reserve. Journal of thoracic and cardiovascular surgery 2011; 141(2):459-462
  • Demmy TL, Nwogu CE, Yendamuri S. Thoracoscopic right extrapleural pneumonectomy after neoadjuvant chemotherapy. Innovations (Philadelphia, Pa.) 2010; 5(3):202 (Abstract #TV5)
  • Demmy TL, Nwogu C, Solan P, Yendamuri S, Wilding G, DeLeon O. Chest tube-delivered bupivacaine improves pain and decreases opioid use after thoracoscopy. Annals of thoracic surgery 2009; 87(4):1040-1046; discussion 1046-1047
  • Demmy TL, Tomaszewski G, Dy GK, Yendamuri S, Nwogu C, Pendyala L, Ramnath N, Adjei AA. Thoracoscopic organ suffusion for regional lung chemotherapy (preliminary results). Annals of thoracic surgery 2009; 88(2):385-390; discussion 390-391
  • Sahai RK, Nwogu CE, Yendamuri S, Tan W, Wilding GE, Demmy TL. Is thoracoscopic pneumonectomy safe?. Annals of thoracic surgery 2009; 88(4):1086-1092
  • Simpson-Abelson MR, Balu-Iyer S, Kelleher Jr RJ, Loyall JL, Yokota SJ, Demmy TL, Odunsi K, Iyer V, Pang WM, Purohit VS, Bankert RB. IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments. Clinical immunology (Orlando, Fla.) 2009; 132(1):71-82
  • Yendamuri S, Nwogu CE, Demmy TL. Thoracoscopic lobectomy with chest wall resection after neoadjuvant therapy. Innovations (Philadelphia, Pa.) 2009; 4(1):36-38
  • Demmy TL, Platis IE, Nwogu C, Yendamuri S. Thoracoscopic extrapleural pneumonectomy for mesothelioma. Annals of thoracic surgery 2011; 91(2):616-618
  • Mallick R, Demmy T. Regional lung chemotherapy techniques. Innovations (Philadelphia, Pa.) 2011; 6(1):1-9
  • Demmy TL. Invited commentary. Annals of thoracic surgery 2008; 86(4):1103
  • Demmy TL, Nwogu C. Is video-assisted thoracic surgery lobectomy better? Quality of life considerations. Annals of thoracic surgery 2008; 85(2):S719-S728
  • Demmy TL. Invited commentary. Annals of thoracic surgery 2007; 84(1):196
  • Demmy TL. Thoracoscopic lobectomy for impaired or complex patients: an update. Annals of thoracic surgery 2007; 83(4):1578
  • Demmy TL. How do surgeons randomize between different levels of surgical trauma? Commentary on: Video-assisted thoracic surgery in lung cancer resection - A meta-analysis and systematic review of controlled trials. Innovations (Philadelphia, Pa.) 2007; 2(6):303-305
  • Demmy TL. Optimizing surgical therapies: Introduction. Seminars in oncology 2007; 34(3):175-176
  • Demmy TL, Dunn KB. Surgical and nonsurgical therapy for lung metastasis: indications and outcomes. Surgical oncology clinics of North America 2007; 16(3):579-605, ix
  • Gushchin V, Demmy TL, Kane JM 3rd. Surgical management of metastatic peritoneal or pleural disease. Seminars in oncology 2007; 34(3):215-225
  • Ramnath N, Demmy TL, Antun A, Natarajan N, Nwogu CE, Loewen GM, Reid ME. Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival. Annals of thoracic surgery 2007; 83(5):1831-1836
  • Jayaprakash V, Cheng C, Reid M, Dexter EU, Nwogu CE, Hicks W, Sullivan M, Demmy TL, Yendamuri S. Previous head and neck cancers portend poor prognoses in lung cancer patients. Annals of thoracic surgery 2011; 92(3):1056-1061
  • Cengel K, Yendamuri S, Demmy TL, Culligan M, Maccready K, Sterman DH, Stevenson J, Busch T, Glatstein E, Hahn S, Friedberg J. The effect of 24 versus 48 hour drug light interval on the toxicity of HPPH-mediated PDT in patients with malignant pleural mesothelioma undergoing radical pleurectomy. Journal of thoracic oncology 2011; 6(6):S1369
  • Cummings KM, Hyland A, Zevon M, Kelly M, Long MA, Demmy TL, Dexter E, Reed R, Epstein J, Houston T, Jenkins D, Mahoney M, O'Connor R, Marshall JR, Reid ME, Smith JL, Chmura M, Warren GW. An institutional universal standardized tobacco use assessment and intervention in cancer patients : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e16543
  • Demmy TL. Emerging endoscopic staging techniques. Journal of thoracic oncology 2009; 4(9 Suppl. 1):S273-S274
  • Ghadersohi A, Bogner PN, Fayazi Z, Demmy TL, Reid M, Wilding G, Reska N, Slocum H, Groth J, Azrak RG, Rustum YM, Li F. Downregulation of PDEF expression in lung carcinoma is associated with up regulation of survivin and malignant potential. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:797
  • Sharma R, Yang GY, Nava HR, Demmy TL, Nwogu CE, Yendamuri SS, Lamonica D, Tan W, Iyer RV, Khushalani NI. A single institution experience with neoadjuvant chemoradiation (CRT) with irinotecan (I) and cisplatin (C) in locally advanced esophageal carcinoma (LAEC). Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #e15619
  • Hennon M, Sahai RK, Yendamuri S, Tan W, Demmy TL, Nwogu C. Safety of thoracoscopic lobectomy in locally advanced lung cancer. Annals of surgical oncology 2011; 18(13):3732-3736
  • Yendamuri S, Demmy TL. Lobectomy for patients with limited lung function. Seminars in thoracic and cardiovascular surgery 2011; 23(3):191-195
  • Yendamuri S, Gold D, Jayaprakash V, Dexter E, Nwogu C, Demmy T. Is sublobar resection sufficient for carcinoid tumors? . Annals of thoracic surgery 2011; 92(5):1774-1778; discussion 1778-9
  • Demmy TL. Invited commentary. Annals of thoracic surgery 2012; 93(2):379-380
  • Demmy TL, Mayfield WR. Anvil extension technology in thoracic surgery. Annals of thoracic surgery 2012; 93(4):1280-1284
  • Smith R, Demmy TL. Pulmonary metastasectomy for soft tissue sarcoma. Surgical oncology clinics of North America 2012; 21(2):269-286
  • Hennon MW, Hylander B, Morrison C, Miller A, Groman A, Dexter E, Yendamuri S, Demmy TL, Adjei A, Reid M, Repasky E, Nwogu C. Predicting NSCLC outcomes based on tumor growth in SCID mice. Proceedings of the American Association for Cancer Research Annual Meeting 2011; 52:Abstract #1610
  • Nwogu CE, Groman A, Fahey D, Yendamuri S, Dexter E, Demmy TL, Miller A, Reid M. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. Annals of thoracic surgery 2012; 93(5):1614-1619; discussion 1619-1620
  • Warren GW, Zevon M, Hyland A, Hysert P, Reed R, Long MA, Houston T, Mahoney M, Demmy TL, Cummings KM. Outcomes from an electronic medical record (EMR)-based standardized tobacco assessment and cessation program in a NCI-designated comprehensive cancer center. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #1529
  • Farooq A, Dy GK, Demmy TL, Bogner P, Nowadly C, Tan W, Chen H, Yendamuri SS, Nwogu CE, Bushunow PW, Adjei AA, Ramnath N. Phase II study of perioperative chemotherapy with cisplatin (C) and pemetrexed (P) in non-small cell lung cancer (NSCLC) : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2012; 30(15 Suppl.):Abstract #e17535
  • Yendamuri S, Caty L, Pine M, Adem S, Bogner P, Miller A, Demmy TL, Groman A, Reid M. Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis. Surgery 2012; 152(3):397-402
  • Demmy TL, Gu L, Burkhalter JE, Toloza EM, D'Amico TA, Sutherland S, Wang X, Archer L, Veit LJ, Kohman L, the Cancer and Leukemia Group B. Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102). Journal of the National Comprehensive Cancer Network : JNCCN 2012; 10(8):975-982
  • Demmy TL, Yendamuri S, Hennon MW, Dexter EU, Picone AL, Nwogu C. Thoracoscopic maneuvers for chest wall resection and reconstruction. Journal of thoracic and cardiovascular surgery 2012; 144(3):S52-S57
  • Yendamuri S, Demmy TL. Is VAMLA/TEMLA the new standard of preresection staging of non-small cell lung cancer?. Journal of thoracic and cardiovascular surgery 2012; 144(3):S14-S17

Cancer Can't Win

More patients are being diagnosed with cancer every day.

Here at Roswell Park Cancer Institute, we must continue to do what we do best – to understand, prevent and cure cancer. Because if we don’t, cancer wins. And Cancer Can’t Win.

  • With more than 3,000 scientific, academic and medical minds – Cancer Can’t Win.
  • When we are leading an advanced genetic program and creating next generation cancer vaccines to prevent it – Cancer Can’t Win.
  • When we are starting 13 new companies to advance our discoveries and share them with the world – Cancer Can’t Win.

Learn more about why Cancer Can’t Win

close